Michael Vesey - 05 May 2021 Form 4 Insider Report for Wayside Technology Group, Inc. (CLMB)

Reporting relationship: Vice President & CFO
Issuer ticker: CLMB
Reported as of: 05 May 2021
Net transaction value: -$25,374
SEC form: 4
Accepted by SEC: 07 May 2021, 15:12:09 UTC
Prior SEC filing: 07 May 2021
Next SEC filing: 10 Sep 2021
Source filing: View source filing
Reporting owner signature: /s/ Michael Vesey

Key filing fact

Michael Vesey filed Form 4 for Wayside Technology Group, Inc. (CLMB) on 07 May 2021.

Key facts

This page summarizes Michael Vesey's Form 4 filing for Wayside Technology Group, Inc. (CLMB).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 07 May 2021, 15:12.

Change

Previous filing in this sequence was filed on 07 May 2021.
Current net transaction value: -$25,374.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLMB transaction

Common Stock

Small acquisition under Rule 16a-6

Transaction value: $2,706
Shares: +107
Change %: +0.23%
Price: $25.29
Shares after: 45,826
Date: 17 Mar 2021
Ownership: Direct

CLMB transaction

Common Stock

Tax liability

Transaction value: $28,080
Shares: -1,125
Change %: -2.5%
Price: $24.96
Shares after: 44,701
Date: 05 May 2021
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Shares withheld at vesting of restricted stock for purposes of meeting the reporting person's tax obligations.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .